Alex Mulmi

Interests

No activities entered.

Courses

No activities entered.

Scholarly Contributions

Journals/Publications

• Shrestha, A., Mulmi, A., & Munankarmi, R. (2019). Statins and Abnormal Liver Enzymes.. South Dakota Journal of Medicine.
  More info

  Statins are a group of essential medications used in ischemic heart disease, stroke, and peripheral vascular disease. In patients with these medical conditions, they have been proven to decrease mortality and morbidity. However, statins can cause transient elevation of liver enzymes in some patients, which has led to the unnecessary cessation of these agents prematurely. Physicians also face a dilemma when determining if they should utilize statins in patients whose liver enzymes are elevated at baseline. This dilemma may prevent physicians from prescribing statins when clinically indicated, and safe. The purpose of this article is to review existing literature that provides guidance on the utilization of statins in clinical scenarios where liver enzymes are elevated at baseline or when liver enzymes increase after the initiation of statin-based therapy.
• Mulmi, A., Desai, N., & Hunter, K. (2016). OBESITY PARADOX IN PATIENTS WITH HEART FAILURE READMISSIONS: AN ANALYSIS FROM AHA “GET WITH THE GUIDELINES” HEART FAILURE. JACC. doi:10.1016/s0735-1097(16)31434-6
  More info

  The phenomenon of obesity paradox which is mild to moderate obesity confers survival benefit over normal weight is well described in patients with chronic heart failure. Our study evaluated the presence of obesity on 30 day readmissions in patients admitted with heart failure. We studied 3,758